Failure of alemtuzumab therapy to control MOG encephalomyelitis.
Wildemann B, Jarius S, Schwarz A, Diem R, Viehöver A, Hähnel S, Reindl M, Korporal-Kuhnke M.
Wildemann B, et al. Among authors: hahnel s.
Neurology. 2017 Jul 11;89(2):207-209. doi: 10.1212/WNL.0000000000004087. Epub 2017 Jun 9.
Neurology. 2017.
PMID: 28600462
No abstract available.